RxSight $50 million follow-on offering
The stock is listed on the Nasdaq Global Market
Davis Polk advised the sole bookrunning manager in connection with a $50 million SEC-registered follow-on offering of 4,000,000 shares of common stock by RxSight, Inc. The underwriter has been granted an option to purchase up to 600,000 additional shares. The common stock is listed on the Nasdaq Global Market under the symbol “RXST.”
Based in Aliso Viejo, California, RxSight is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Paula Gergen and Rong (Fiona) Huang. Partner Frank J. Azzopardi and associates David A. Frey and Lauren Nathan provided intellectual property advice. Partner Lucy W. Farr and associate Ted Lee provided tax advice. Members of the Davis Polk team are based in the Northern California and New York offices.